NYSE · G

GENPACT LIMITED

$32.18 +$0.92 (+2.94%) 1D After hours
Charting by TradingView

Key Metrics

$5.30B
Market cap
9.30×
P/E · TTM
$5.16B
Revenue · TTM
$569.63M
Net income
EPS · TTM $3.19
Dividend yield 2.3%
Free cash flow $668.73M
Beta · 1Y 0.29
EBITDA · TTM $820.43M
Gross margin 36.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 30
    From its Jan 29 high, the share price fell 38%.

    Peak close $44.61 on Jan 29; trough close $27.50 on Jun 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -38%
  • Feb 3
    The stock moved -11.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$5.30B
Enterprise value$5.91B
Shares outstanding169.5M
52-wk range$26.85 – $48.64
Avg volume · 20D1.4M
Net cash −$608.26M
Book value / share$13.87
IndustryServices-Management Consulting Services
ExchangeNYSE
About GENPACT LIMITED
IPO dateAug 2, 2007
Employees145000

Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E9.30
P/S1.03
P/FCF7.92
EV/EBITDA7.20
EV/Sales1.14
Graham №$31.57

Profitability

Gross 36.3%
Operating 14.5%
Net 11.0%
FCF 13.0%
ROE / ROIC 23.4% · 18.5%

Financial Health

Current ratio1.69
Quick ratio—
Debt / equity0.62
Debt / EBITDA 1.87
Net cash −$608.26M
Working capital$979.00M

Cash Flow · TTM

Operating CF $748.89M
Capex −$80.15M
Free cash flow $668.73M
Buybacks —
Dividends paid $119.74M
Shareholder yield 2.3%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

2.9
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$31.57 vs $32.18
Trades 1.0× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings